Glycopegylated factor IX

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8404809
APP PUB NO 20100081791A1
SERIAL NO

12605028

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Conjugates between Factor IX and PEG moieties are disclosed in the present application. The conjugates are linked via a glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. Conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • NOVO NORDISK A/S

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bayer, Robert J San Diego, US 61 2131
Bowe, Caryn L Doylestown, US 5 68
DeFrees, Shawn North Wales, US 148 5846
Panneerselvam, Krishnasamy Poway, US 9 161

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation